Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Relapsed or Refractory Acute Leukemia
Related studies linked through entity extraction aliases.